KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Finished Goods (2016 - 2019)

NovoCure's Finished Goods history spans 6 years, with the latest figure at $12.9 million for Q2 2019.

  • On a quarterly basis, Finished Goods rose 6.49% to $12.9 million in Q2 2019 year-over-year; TTM through Jun 2019 was $12.9 million, a 6.49% increase, with the full-year FY2018 number at $13.0 million, up 39.77% from a year prior.
  • Finished Goods hit $12.9 million in Q2 2019 for NovoCure, down from $14.4 million in the prior quarter.
  • Over the last five years, Finished Goods for NVCR hit a ceiling of $14.4 million in Q1 2019 and a floor of $4.9 million in Q3 2015.
  • Historically, Finished Goods has averaged $10.3 million across 5 years, with a median of $10.9 million in 2017.
  • Biggest five-year swings in Finished Goods: soared 232.8% in 2015 and later tumbled 32.63% in 2017.
  • Tracing NVCR's Finished Goods over 5 years: stood at $5.5 million in 2015, then soared by 120.12% to $12.0 million in 2016, then fell by 22.47% to $9.3 million in 2017, then skyrocketed by 39.77% to $13.0 million in 2018, then fell by 0.85% to $12.9 million in 2019.
  • Business Quant data shows Finished Goods for NVCR at $12.9 million in Q2 2019, $14.4 million in Q1 2019, and $13.0 million in Q4 2018.